Article Details

Inebilizumab Effective in NMOSD Despite Fc Receptor Polymorphisms - Physician's Weekly

Retrieved on: 2022-11-08 20:14:38

Tags for this article:

Click the tags to see associated articles and topics

Inebilizumab Effective in NMOSD Despite Fc Receptor Polymorphisms - Physician's Weekly. View article details on hiswai:

Excerpt

Afucosylated monoclonal antibodies are engineered to enhance affinity for ... cytokine release, antibody-dependent cellular cytotoxicity (ADCC), ...

Article found on: www.physiciansweekly.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up